XT
ONCY

XTX Topco’s Oncolytics Biotech ONCY Stock Holding History

XTX Topco’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$93.2K Buy
109,758
+31,097
+40% +$30.9K ﹤0.01% 3127
2025
Q4 		$68.8K Buy
+78,661
New +$85K ﹤0.01% 2749
2025
Q3 		– Sell
-12,631
Closed -$9.76K – 3066
2025
Q2 		$9.76K Buy
+12,631
New +$6.69K ﹤0.01% 2234

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco's ONCY Position: Q1 2026 in Review

XTX Topco increased its Oncolytics Biotech (ONCY) stake by 40% in Q1 2026, buying an estimated $30.9K and bringing the position to 109,758 shares worth $93.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3127.

XTX Topco first reported a position in ONCY in Q2 2025 and has held it in 3 quarters since. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • XTX Topco held 109,758 shares of Oncolytics Biotech worth $93.2K as of Q1 2026.
  • XTX Topco bought 31,097 Oncolytics Biotech shares in Q1 2026, an estimated $30.9K.
  • Oncolytics Biotech made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3127 holding.
  • XTX Topco first reported a position in Oncolytics Biotech in Q2 2025 and has held it in 3 quarters since.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.